Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).


CSE:THC - Post by User

Bullboard Posts
Comment by Nikopainon Oct 29, 2017 9:24pm
75 Views
Post# 26874464

RE:RE:RE:Just tried THC product AMA

RE:RE:RE:Just tried THC product AMAoh and as i said in my review, i agree with you that the low price is VERY VERY VERY attractive to patients becuase this sh***t is reallly expensive compared to what we were used to pay on the black market, but most people want to purchase legally so we are trying to get good quality and good price which THC does offer. 

But the caveat is that they are experiencing some problems with logistics (which can be easily solved honestly) but the biggest concern is that if they have an influx of patients with small production capabilities, they will piss of patients once their products are unavailable,so far that hasnt happen. 

What they really need to do is inform shareholders on theri production capacity and expansion plans. They say they will be ready for REC, but we have yet to see plans. If they do and it makes sense, ill be back
Bullboard Posts